At Biogen, our mission is clear: we are pioneers in neuroscience.

Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.

Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).

We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience. 

Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society. 

Biogen Research Triangle Park, Durham, NC, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Cambridge, MA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Weston, MA 02493, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Long Island, New York, USA
May 16, 2019
The Biogen neurology sales force is looking to recruit proven sales achievers with at least three to five years of experience in pharma, specialty, hospital, and/or biotech sales. In this field based, specialty sales representative position you will be called upon to sell our Neurology products with key stakeholders in the Multiple Sclerosis community: including Neurologists, allied health professionals, and local MS chapters. The Territory Business Manager is responsible for developing plans for their business territory and executing on these plans in order to bring the greatest benefit to the greatest number of MS patients.  In this role, you will convey complex clinical and reimbursement information to customers and key stakeholders so that all appropriate patients can benefit from therapy. You must be able to utilize strong interpersonal skills to establish relationships of trust that allow for directed probing to uncover the customer's needs and develop solutions within the Biogen framework that meet these needs. This position works closely with cross functional peers to ensure that the Biogen suite of services is made available as needed. Qualifications • Minimum 3-5+ years B2B and/or pharmaceutical/biotech sales experience required • Proven track record of success as demonstrated by consistent high ranking (top 30%) over 3 years (+), achievement awards, etc. • Proven ability to drive results in a difficult market • Documented experience working in a collaborative team setting • Customer and patient focused and able to drive for results • Must have the desire and capabilities to help us achieve new levels of success as we look to the future • Driving is an essential duty of this job; candidates must have a valid driver’s license to be considered Education • BS/BA preferred, MBA a plus
Biogen Milwaukee, WI, USA
May 16, 2019
The Biogen neurology sales force is looking to recruit proven sales achievers with at least three to five years of experience in pharma, specialty, hospital, and/or biotech sales. In this field based, specialty sales representative position you will be called upon to sell our Neurology products with key stakeholders in the Multiple Sclerosis community: including Neurologists, allied health professionals, and local MS chapters. The Territory Business Manager is responsible for developing plans for their business territory and executing on these plans in order to bring the greatest benefit to the greatest number of MS patients.  In this role, you will convey complex clinical and reimbursement information to customers and key stakeholders so that all appropriate patients can benefit from therapy. You must be able to utilize strong interpersonal skills to establish relationships of trust that allow for directed probing to uncover the customer's needs and develop solutions within the Biogen framework that meet these needs. This position works closely with cross functional peers to ensure that the Biogen suite of services is made available as needed. Qualifications • Minimum 3-5+ years B2B and/or pharmaceutical/biotech sales experience required • Proven track record of success as demonstrated by consistent high ranking (top 30%) over 3 years (+), achievement awards, etc. • Proven ability to drive results in a difficult market • Documented experience working in a collaborative team setting • Customer and patient focused and able to drive for results • Must have the desire and capabilities to help us achieve new levels of success as we look to the future • Driving is an essential duty of this job; candidates must have a valid driver’s license to be considered Education • BS/BA preferred, MBA a plus
Biogen Arcadia, CA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Weston, MA 02493, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Research Triangle Park, Durham, NC, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Cambridge, MA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Cambridge, MA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Cambridge, MA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Cambridge, MA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Cambridge, MA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Cambridge, MA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Cambridge, MA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Cambridge, MA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Cambridge, MA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Cambridge, MA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Research Triangle Park, Durham, NC, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 
Biogen Cambridge, MA, USA
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives.